Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Adrenal Gland Neoplasms 5Adrenal incidentaloma 3Pheochromocytoma 2Hypertension 2Cushing Syndrome 2Urinary Bladder Neoplasms 1Osteoporosis 1Obesity 1Hypokalemia 1Hypercholesterolemia 1Hyperaldosteronism 1Diabetes Mellitus 1Carcinoma, Renal Cell 1Adrenocortical Carcinoma 1Adrenocortical Adenoma 1

Interventions

Everolimus 5pembrolizumab 2cabozantinib 2Trastuzumab 2Nivolumab 2vatalanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1spartalizumab 1romidepsin 1regorafenib 1pentetreotide 1guadecitabine 1fostamatinib 1exemestane 1entrectinib 1entinostat 1belzutifan 1avelumab 1alectinib 1Vinorelbine 1Sirolimus 1Rosiglitazone 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Nephrectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Adrenalectomy × Endocrine × Clear all
NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡